Bryan M. Reasons Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Bryan M. Reasons.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bryan M. Reasons. Bryan M. Reasons is a Chief Financial Officer in IMPAX LABORATORIES INC ($IPXL) and a Director in Aclaris Therapeutics, Inc. ($ACRS) and a EVP & CFO in Mallinckrodt plc ($MNK) and a Director in Recro Pharma, Inc. ($REPH) and a CFO in Amneal Pharmaceuticals, Inc. ($AMRX).
Address: C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD 94544 CA
Companies in which Bryan M. Reasons is an Insider
Aclaris Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: Director
Holdings: 16,209 shares
Current Value: $409,277
Latest Transaction: Jun 08 2020
$ACRS Market Capitalization: $537.94M
$ACRS Previous Close: $25.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Amneal Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: CFO
Holdings: 82,986 shares
Latest Transaction: Aug 23 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Impax Laboratories, LLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 08 2018
$IPXL Market Capitalization: $952.26M
$IPXL Previous Close: $13.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mallinckrodt plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: EVP & CFO
Holdings: 11,593 shares
Current Value: $587,533
Latest Transaction: Dec 07 2020
$MNK Market Capitalization: $5.32B
$MNK Previous Close: $50.68
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Recro Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: Director
Holdings: 67,429 shares
Current Value: $542,803
Latest Transaction: Apr 22 2021
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Bryan M. Reasons
Sentiment: All, ACRS, AMRX, IPXL, MNK, REPH
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | A | 1.71 | 38,012 | 65,001 | 38,012 | |
| Apr 22 2021 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Grant | A | 0.00 | 26,923 | 0 | 67,429 | 40.5 K to 67.4 K (+66.47 %) |
| Dec 07 2020 | MNK | Mallinckrodt plc | Reasons Bryan M. | EVP & CFO | Sell | S | 0.17 | 5,400 | 891 | 11,593 | 17 K to 11.6 K (-31.78 %) |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Option Exercise | M | 0.00 | 7,333 | 0 | 0 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Option Exercise | A | 1.41 | 16,500 | 23,265 | 16,500 | |
| Jun 08 2020 | ACRS | Aclaris Therapeuti ... | Reasons Bryan M. | Director | Buy | M | 0.00 | 7,333 | 0 | 16,209 | 8.9 K to 16.2 K (+82.62 %) |
| May 11 2020 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 |